Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Phase 1 Study of Alvocidib (DSP-2033) in Combination with Cytarabine/Mitoxantrone (ACM) or Cytarabine/Daunorubicin (A+7+3) in Japanese Patients (Pts) with Acute Myeloid Leukemia (AML)

Yasuyoshi Morita, Takayuki Ikezoe, MD PhD, Kiyoshi Ando, Masahiro Onozawa, Takahisa Yamane, MD PhD, Naoko Hosono, MD PhD, Toru Kiguchi, Hiromi Iwasaki, Toshihiro Miyamoto, MD PhD, Miho Kasai, Saori Sugimoto, Yasushi Miyazaki, MD PhD, Masahiro Kizaki, MD, Koichi Akashi, MD PhD

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-134078

Published: 2020

Journal Articles

Combining the Number of Infectious Episodes and Interval of Chemotherapy to Transplantation May Predict a Transplant Outcome in Patients with Acute Myeloid Leukemia: A Retrospective Analysis of JALSG AML201 Study

Satoshi Kaito, MD, Noriko Doki, MD PhD, Yuho Najima, MD, Shigeki Ohtake, MD PhD, Hitoshi Kiyoi, MD PhD, Hiroyuki Fujita, MD PhD, Yasushi Miyazaki, MD PhD, Noriko Usui, MD PhD, Hirokazu Okumura, MD PhD, Koichi Miyamura, MD PhD, Emiko Sakaida, MD PhD, Atsushi Fujieda, MD PhD, Nagai Tadashi, MD PhD, Takahisa Yamane, MD PhD, Ohnishi Kazunori, MD PhD, Tomoki Naoe, MD PhD, Kazuteru Ohashi, MD PhD

Blood (2018) 132 (Supplement 1): 4643.

https://doi.org/10.1182/blood-2018-99-114565

Published: 2018

Journal Articles

A Retrospective Study of Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Clinical Significance of Treatment Intensity and Comprehensive Geriatric Assessment (CGA)

Masahiro Yoshida, MD, Mirei Horiuchi, MD, Hideya Ueda, MD, Kiyoyuki Hagihara, MD PhD, Hiroshi Kanashima, MD PhD, Takafumi Nakao, MD PhD, Takahisa Yamane, MD PhD

Blood (2014) 124 (21): 4441.

https://doi.org/10.1182/blood.V124.21.4441.4441

Published: 2014

Journal Articles

Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study

Blood (2011) 117 (8): 2358–2365.

https://doi.org/10.1182/blood-2010-03-273243

Published: 2011

Journal Articles

A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study

Blood (2011) 117 (8): 2366–2372.

https://doi.org/10.1182/blood-2010-07-295279

Published: 2011

Journal Articles

Factors That Contribute to Long-Term Survival In Patients with Leukemia Not In Remission at Allogeneic Hematopoietic Cell Transplantation

Blood (2010) 116 (21): 3551.

https://doi.org/10.1182/blood.V116.21.3551.3551

Published: 2010

Journal Articles

Feasibility of Cyclosporine and Short-Term Methotrexate for Graft-Vs.-Host disease Prophylaxis in T-Cell-Replete, Reduced-Intensity Allogeneic Bone Marrow Transplantation From Unrelated Donors.

Takahiko Nakane, MD, PhD, Hirohisa Nakamae, MD, PhD, Hideo Koh, MD, Mika Nakamae, MD, PhD, Yoshiki Hayashi, MD, Mitsutaka Nishimoto, MD, Takuro Yoshimura, MD, Eri Inoue, MD, Atsushi Inoue, MD, Ran Aimoto, MD, Mizuki Aimoto, MD, Yoshiki Terada, MD, PhD, Ki-Ryang Koh, MD, PhD, Takahisa Yamane, MD, PhD, Masayuki Hino, MD, PhD

Blood (2009) 114 (22): 4347.

https://doi.org/10.1182/blood.V114.22.4347.4347

Published: 2009

Journal Articles

Long-Term Follow-up of the Randomized JALSG AML 201 Study Comparing High Dose Ara-C Therapy with Conventional Consolidation Therapy in Adult Acute Myeloid Leukemia (AML)

Blood (2008) 112 (11): 135.

https://doi.org/10.1182/blood.V112.11.135.135

Published: 2008

Journal Articles

Updated Results of JALSG AML201 Study Comparing Intensified Daunorubicin with Idarubicin in Patients with De Novo Acute Myeloid Leukemia: Effect of Hematopoietic Stem Cell Transplantation.

Blood (2008) 112 (11): 2171.

https://doi.org/10.1182/blood.V112.11.2171.2171

Published: 2008

Journal Articles

The Impact of Relative Dose Intensity of Rituximab-CHOP on Survival in Diffuse Large B-Cell Lymphoma Patients

Yoshiki Terada, MD, PhD, Hirohisa Nakamae, MD, PhD, Ran Moriguchi, MD, Hiroshi Kanashima, MD, PhD, Erina Sakamoto, MD, PhD, Dai Momose, MD, Mizuki Aimoto, MD, Shuichirou Okamoto, MD, Eri Wada, MD, Hideo Koh, MD, Takahiko Nakane, MD, Yasunobu Takeoka, MD, Ki- Ryang Koh, MD, PhD, Takahisa Yamane, MD, PhD, Yoshitaka Nakao, MD, PhD, Kensuke Ohta, MD, PhD, Atsuko Mugitani, MD, PhD, Hirofumi Teshima, MD, PhD, Masayuki Hino, MD, PhD

Blood (2008) 112 (11): 4931.

https://doi.org/10.1182/blood.V112.11.4931.4931

Published: 2008

Journal Articles

Possible Involvement of γδ-T Cells in the Development of Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Ki-Ryang Koh, MD, PhD, Hirohisa Nakamae, M.D., Ph.D., Kensuke Ohta, M.D., Ph.D., Hongzhang Li, M.D., Hideo Koh, M.D., Takahiko Nakane, M.D., Yasunobu Takeoka, M.D., Asao Hirose, M.D., Ph.D., Kiyoyuki Hagihara, M.D., Ph.D., Erina Sakamoto, M.D., Ph.D., Mika Nakamae, M.D., Ph.D., Yoshiki Terada, M.D., Ph.D., Takahisa Yamane, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2007) 110 (11): 1971.

https://doi.org/10.1182/blood.V110.11.1971.1971

Published: 2007

Journal Articles

The Impact of Relative Dose Intensity (RDI) of CHOP on Outcome of Diffuse Large B-Cell Lymphoma: Results of a Single Center Study.

Yoshiki Terada, MD, PhD, Hirohisa Nakamae, M.D., Ph.D., Takahiko Nakane, M.D., Hideo Koh, M.D., Yasunobu Takeoka, M.D., Ran Moriguchi, M.D., Mizuki Aimoto, M.D., Yuki Akazawa, M.D., Eri Wada, M.D., Hiroshi Kanashima, M.D., Ph.D., Erina Sakamoto, M.D., Ph.D., Ki-Ryang Koh, M.D., Ph.D., Takahisa Yamane, M.D., Ph.D., Kensuke Ohta, M.D., Ph.D., Yoshitaka Nakao, M.D., Ph.D., Hirofumi Teshima, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2007) 110 (11): 4456.

https://doi.org/10.1182/blood.V110.11.4456.4456

Published: 2007

Journal Articles

Non-TBI, Non-ATG Containing Fludarabine-Based Regimen for Unrelated Allogeneic Reduced Intensity Transplantation.

Hirohisa Nakamae, MD, PhD, Takahiko Nakane, M.D., Hideo Koh, M.D., Yasunobu Takaoka, M.D.,Ph.D., Erina Sakamoto, M.D.,Ph.D., Hiroshi Kanashima, M.D.,Ph.D., Hiroyoshi Ichihara, M.D., Mika Nakamae, M.D.,Ph.D., Ki-Ryang Koh, M.D.,Ph.D., Takahisa Yamane, M.D.,Ph.D., Masayuki Hino, M.D.,Ph.D.

Blood (2006) 108 (11): 5382.

https://doi.org/10.1182/blood.V108.11.5382.5382

Published: 2006

Journal Articles

Decreased Serum Levels of Surfactant Protein D (SP-D) Prior Transplant Is Associated with the Development of Bronchiolitis Obliterans (BO) and Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Hematopoietic Stem Cell Transplantation.

Takahiko Nakane, MD, Hirohisa Nakamae, M.D.,Ph.D., Hiroshi Kamoi, M.D.,Ph.D., Hideo Koh, M.D., Yasunobu Takeoka, M.D., Erina Sakamoto, M.D.,Ph.D., Hiroshi Kanashima, M.D.,Ph.D., Hiroyoshi Ichihara, M.D., Mika Nakamae, M.D.,Ph.D., Ki-Ryang Koh, M.D.,Ph.D., Takahisa Yamane, M.D.,Ph.D., Masayuki Hino, M.D.,Ph.D.

Blood (2006) 108 (11): 2915.

https://doi.org/10.1182/blood.V108.11.2915.2915

Published: 2006

Journal Articles

Preferential Th2 Polarization at the Onset of Thrombotic Microangiopathy (TMA): Immunological Comparison of TMA Versus Acute GVHD in Terms of Peripheral T Cell Subsets, Dendritic Cell Subsets and Cytokine Profiles.

Ki-Ryang Koh, MD, PhD, Hirohisa Nakamae, M.D., Ph. D., Kensuke Ohta, M.D., Ph. D., Hideo Koh, M.D., Takahiko Nakane, M.D., Mika Nakamae, M.D., Ph. D., Hiroshi Kanashima, M.D., Ph. D., Kiyoyuki Hagihara, M.D., Ph. D., Erina Sakamoto, M.D., Ph. D., Yoshiki Terada, M.D., Ph. D., Yasunobu Takeoka, M.D., Asao Hirose, M.D., Ph. D., Takahisa Yamane, M.D., Ph. D., Masayuki Hino, M.D., Ph.D

Blood (2006) 108 (11): 2885.

https://doi.org/10.1182/blood.V108.11.2885.2885

Published: 2006

Journal Articles

Randomized Clinical Trial of Induction Therapy Comparing Intensified Daunorubicin with Idarubicin in Patients with Previously Untreated De Novo Acute Myeloid Leukemia (JALSG AML201 Study).

Blood (2006) 108 (11): 2000.

https://doi.org/10.1182/blood.V108.11.2000.2000

Published: 2006

Journal Articles

Chronic Myeloid Leukemia in Two Patients with Gastrointestinal Stromal Tumor.

Erina Sakamoto, MD, Hirohisa Nakamae, MD, Ki Ryang Koh, MD, Takahisa Yamane, MD, Masayuki Hino, MD

Blood (2006) 108 (11): 4767.

https://doi.org/10.1182/blood.V108.11.4767.4767

Published: 2006

Journal Articles

Postremission Therapy in Adult Acute Myeloid Leukemia (AML): A Randomized Comparison between High Dose Ara-C Therapy and Conventional Consolidation Therapy (JALSG AML 201 Study).

Blood (2006) 108 (11): 2005.

https://doi.org/10.1182/blood.V108.11.2005.2005

Published: 2006

Journal Articles

Triphasic Exponential Decline of BCR-ABL Transcripts during Imatinib Therapy for Chronic Myelogenous Leukemia.

Koichi Miyamura, Kazunori Ohnishi, Tomoki Naoe, Hitoshi Takeuchi, Nishimura Yoshiki, Fumiharu Yagasaki, Shin Fujisawa, Yukihiko Kimura, Toshiko Motoji, Kiyotoshi Imai, Takahisa Yamane, Shinichiro Yoshida, Shuichi Miyawaki, Yoshio Saburi, Kunio Kitamura, Ryuzo Ohno

Blood (2005) 106 (11): 1107.

https://doi.org/10.1182/blood.V106.11.1107.1107

Published: 2005

Journal Articles

Risk Factor Analysis for Thrombotic Microangiopathy after Reduced Intensity or Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation.

Hirohisa Nakamae, MD, PhD, Takahisa Yamane, MD, PhD, Hagihara Kiyoyuki, MD., PhD., Yasunobu Takeoka, MD., Erina Sakamoto, MD., PhD., Takahiko Nakane, MD., Mika Nakamae, MD., PhD., Ki-Ryang Koh, MD., PhD., Kensuke Ohta, MD., PhD., Masayuki Hino, MD., PhD.

Blood (2005) 106 (11): 1775.

https://doi.org/10.1182/blood.V106.11.1775.1775

Published: 2005

NARROW

Phase 1 Study of Alvocidib (DSP-2033) in Combination with Cytarabine/Mitoxantrone (ACM) or Cytarabine/Daunorubicin (A+7+3) in Japanese Patients (Pts) with Acute Myeloid Leukemia (AML)

Combining the Number of Infectious Episodes and Interval of Chemotherapy to Transplantation May Predict a Transplant Outcome in Patients with Acute Myeloid Leukemia: A Retrospective Analysis of JALSG AML201 Study

A Retrospective Study of Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Clinical Significance of Treatment Intensity and Comprehensive Geriatric Assessment (CGA)

Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study

A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study

Factors That Contribute to Long-Term Survival In Patients with Leukemia Not In Remission at Allogeneic Hematopoietic Cell Transplantation

Feasibility of Cyclosporine and Short-Term Methotrexate for Graft-Vs.-Host disease Prophylaxis in T-Cell-Replete, Reduced-Intensity Allogeneic Bone Marrow Transplantation From Unrelated Donors.

Long-Term Follow-up of the Randomized JALSG AML 201 Study Comparing High Dose Ara-C Therapy with Conventional Consolidation Therapy in Adult Acute Myeloid Leukemia (AML)

Updated Results of JALSG AML201 Study Comparing Intensified Daunorubicin with Idarubicin in Patients with De Novo Acute Myeloid Leukemia: Effect of Hematopoietic Stem Cell Transplantation.

The Impact of Relative Dose Intensity of Rituximab-CHOP on Survival in Diffuse Large B-Cell Lymphoma Patients

Possible Involvement of γδ-T Cells in the Development of Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

The Impact of Relative Dose Intensity (RDI) of CHOP on Outcome of Diffuse Large B-Cell Lymphoma: Results of a Single Center Study.

Non-TBI, Non-ATG Containing Fludarabine-Based Regimen for Unrelated Allogeneic Reduced Intensity Transplantation.

Decreased Serum Levels of Surfactant Protein D (SP-D) Prior Transplant Is Associated with the Development of Bronchiolitis Obliterans (BO) and Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Hematopoietic Stem Cell Transplantation.

Preferential Th2 Polarization at the Onset of Thrombotic Microangiopathy (TMA): Immunological Comparison of TMA Versus Acute GVHD in Terms of Peripheral T Cell Subsets, Dendritic Cell Subsets and Cytokine Profiles.

Randomized Clinical Trial of Induction Therapy Comparing Intensified Daunorubicin with Idarubicin in Patients with Previously Untreated De Novo Acute Myeloid Leukemia (JALSG AML201 Study).

Chronic Myeloid Leukemia in Two Patients with Gastrointestinal Stromal Tumor.

Postremission Therapy in Adult Acute Myeloid Leukemia (AML): A Randomized Comparison between High Dose Ara-C Therapy and Conventional Consolidation Therapy (JALSG AML 201 Study).

Triphasic Exponential Decline of BCR-ABL Transcripts during Imatinib Therapy for Chronic Myelogenous Leukemia.

Risk Factor Analysis for Thrombotic Microangiopathy after Reduced Intensity or Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only